rho home
venture capital
fund of funds
private equity
extranet
           2009 News Listings                                                                                            Page 1      
            > View archives    2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008

5/7/09
MiddleBrook Pharmaceuticals Reports First Quarter 2009 Results

5/6/09
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia

5/4/09
ON24 Receives 2009 Frost and Sullivan Global Market Leadership Award for Virtual Events

5/1/09
MiddleBrook Pharmaceuticals Launches MOXATAG(TM) Website, Announces Early Prescription Data for MOXATAG

4/24/09
NitroMed Announces Closing of Acquisition and Determination of Final Merger Consideration

4/20/09
ReachLocal Launches ‘The ReachLocal Xchange,’ The First-Of-Its-Kind Local Advertising Platform

4/19/09
Mersana’s Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting

3/16/09
MiddleBrook Pharmaceuticals Launches MOXATAG(TM), the First and Only FDA-Approved Once-Daily Amoxicillin

3/10/09
Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe

3/5/09
MiddleBrook Pharmaceuticals Reports 2008 Fourth Quarter and Full-Year Financial and Operational Results

3/3/09
IntraLinks Sees 180 Percent Increase in Bankruptcy and Restructuring Deals

2/23/09
ON24 Announces Record Annual Business Performance

2/17/09
Everyday Health Announces Most Successful Quarter to Date [Waterfront Media]

2/19/09
Anacor Announces Positive Results from Phase 2 Psoriasis Trial

2/4/09
Slacker Announces Availability of Mobile Radio Application
for the BlackBerry Storm Smartphone

1/14/09
On24 Survey Shows Explosive Growth for Virtual Events in 2009

1/14/09
Slacker Launches Personal Radio Mobile Application for iPhone

1/12/09
Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate

1/6/09
Anacor Raises $50 Million in Equity Financing - Investments from GlaxoSmithKline, Schering Corporation and Existing Investors

8/6/08
Ospedale Niguarda Ca' Granda-Milano Adopts Latest Technology to Treat Patients with Heart Failure (Orqis)

8/5/08
Silicon Valley’s New El Camino Hospital To Have Complete Wireless Coverage And Full Clinical Mobility With InnerWireless







      
Copyright ©2008 Rho Capital Partners, Inc.